COMPANY

Keya Medical

Location: Seattle, WA · source · Oct 13, 2026

Profile checked Oct 10, 2026

Keywords: Coronary Arterial Disease Coronary Heart Disease Coronary Artery Disease Myocardial Ischemia Shockplus-10

Timeline

Jul 8, 2025 Partnership Partnership / licensing announced Jul 8, 2025. Source: company's own press page. source ↗
Jul 1, 2024 Trial start Not phased (device or behavioral study): The Safety and Performence of ShockPulse-10 in Patients with Coronary Artery Calcification source ↗
May 9, 2023 Trial start —: A CCTA Image Assisted Triage Software for the Assessment of Patients With Suspected Coronary Artery Disease source ↗
Aug 10, 2020 Trial start —: The ADAPT Study: Assessment of the DiAgnostic Performance of DeepVessel FFR in SuspecTed Coronary Artery Disease source ↗

Last 2 years.

Jul 8, 2025 Partnership / licensing announced Jul 8, 2025. Source: company's own press page. source ↗

Record	Title	Phase	Status	Start	Primary completion
NCT06711822	The Safety and Performence of ShockPulse-10 in Patients with Coronary Artery Calcification	Not phased (device or behavioral study)	Recruiting	Jul 1, 2024	Jun 30, 2025 (estimated)
NCT06172985	A CCTA Image Assisted Triage Software for the Assessment of Patients With Suspected Coronary Artery Disease	Not listed	Unknown status (ClinicalTrials.gov)	May 9, 2023	Jun 8, 2023 (actual)
NCT04828590	The ADAPT Study: Assessment of the DiAgnostic Performance of DeepVessel FFR in SuspecTed Coronary Artery Disease	Not listed	Completed	Aug 10, 2020	Dec 1, 2021 (actual)